Table 1.
Gene | Mutation proportion (%) | Protein | Uniprot ID | O-GlcNAc site | Cancer Type | Overlapping site | Protein Change | Annotation |
---|---|---|---|---|---|---|---|---|
TP53 | 37 | P53 | P04637 | S149 | Serous Ovarian Cancer | S149 | S149Ffs*32 | The TP53 S149Ffs*32 mutation is likely oncogenic |
Prostate Adenocarcinoma | S149 | S149Pfs*21 | The TP53 S149Pfs*21 mutation is likely oncogenic | |||||
Pancreatic Adenocarcinoma | S149 | S149Ffs*32 | The TP53 S149Ffs*32 mutation is likely oncogenic | |||||
TTN | 30 | TITIN | Q8WZ42 | T671, T826, S1571, T3501, S4651, T4659, S7613, S10385, S10781, T12007, T14674, S28157, S28450, S33976 | Uterine Endometrioid Carcinoma | T671 | T671S | Unknown |
Uterine Endometrioid Carcinoma | S1571 | S1571T | Unknown | |||||
Cutaneous Melanoma | S1571 | S1571F | Unknown | |||||
MUC16 | 19.3 | MUC16 | Q8WXI7 | S12117, S13054, T13833 | Uterine Endometrioid Carcinoma | S12117 | S12117N | Unknown |
Renal Clear Cell Carcinoma | S13054 | S13054T | Unknown | |||||
Renal Clear Cell Carcinoma | S13054 | S13054F | Unknown | |||||
PIK3CA | 14.1 | PK3CA | P42336 | no data | ||||
CSMD3 | 13.3 | CSMD3 | Q7Z407 | no data | ||||
RYR2 | 13.2 | RYR2 | Q92736 | T1468 | No overlapping sites | |||
LRP1B | 12.7 | LRP1B | Q9NZR2 | no data | ||||
SYNE1 | 12.2 | SYNE1 | Q8NF91 | S1286, T1951, S3382, T4836, T7270 | Serous Ovarian Cancer | T1951 | T1951A | Unknown |
Cutaneous Melanoma | S3382 | S3382N | Unknown | |||||
FLG | 11.4 | FILA | P20930 | na | ||||
USH2A | 11.2 | USH2A | O75445 | na |
no data: could not find human protein in O-GlcNAc database, na: no O-GlcNAc site reported